NCNA ▲ +4.2% - NuCana plc $NCNA - NuCana Presents Preclinical Data Showing NUC-7738 Enhances Carfilzomib Activity in Multiple Myeloma Cell Lines at the 38th EORTC-NCI-AACR Symposium 20-NOV-2026 08:00 AM ET